FDA's abrupt flip‑flop on Moderna's mRNA flu shot highlights growing risks to drugmakers of investing in vaccines
Mar 07, 2026
Drugmakers have been paring back investments in vaccines due to concerns about the FDA approval process. The FDA’s abrupt shift on Moderna's flu vaccine is unlikely to assuage those concerns.
https://www.phillyvoice.com/fda-moderna-flu-shot-vaccines/?utm_source=pv-rss&utm_medium=rss&utm_campaign=pv-site
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service